Algotec Research & Development LTD

Home

About Us

FAQ

Subscribe to our Newsletter

Search:

Language:

HOME

PRODUCTS

PHYSICIAN

PATIENT

PRESS AND MEDIA

MEETINGS

ABOUT US

FAQ

NeuroStimulator PENS therapy®

Algotec is the manufacturer of the NeuroStimulator PENS therapy®, which offers patients the potential for intermediate relief and ongoing management of chronic peripheral neuropathic pain.

Read more...

...................................................

2cm PENS Probe for Intraoral Pain

Mr Barrie T Evans FRCS(Eng & Edin), FDSRCS(Eng),FFDRCS(Ire), Consultant Oral & Maxillofacial Surgeon, Southampton University Hospitals, Hampshire, UK, currently uses Algotec’s 2cm Probes for PENS therapy® procedures.

Mr Evans states that “for the treatment of pain in the terminal branches of the trigeminal nerve i.e. supra orbital, infra orbital and mental, the use of the 2cm probe is a significant advantage. This is because the distance from the skin surface to the target is of course much shorter. The longer (5cm) probe is somewhat unwieldy in this situation. Patients tolerate the 2cm probe far better in this circumstance. The use of Doppler to localise the appropriate neurovascular bundle precludes the need for a longer needle”.

Read more...

...................................................

The Times

'Stimulator PENS therapy: innovative technology of interest.

Algotec Research and Development Limited provide innovative electro-analgesic solutions to improve the quality of care for patients suffering from chronic neuropathic pain...'

Click to see article in the Times newspaper.

...................................................

PENS therapy Clinic

Through Algotec Research and Development Limited, the Dudley Group of Hospitals NHS Foundation Trusts Pain Service introduced Percutaneous Electrical Nerve Stimulation (PENS) as an additional management Option in 2007, and it has since developed as a predominately Nurse led service.

Percutaneous Electrical Nerve Stimulation (PENS) is a relatively new electro analgesic therapy.

Read more...

...................................................

Poster: WSPC - NeuroStimulator PENS therapy® (2012)

"Introduction: It is challenging to treat a well-recognized neuropathic pain in patients with allodynia and hyperalgesic localized areas. The use of analgesic drugs, such as opiates, is not free of risks, in the absence of proven effectiveness. The availability of a new device with limited invasiveness for Percutaneous Electrical Nerve Stimulation (PENS), could provide a modern chance for the treatment of chronic neuropathic non-cancer pain. Aim of this observational and multicentric study is to validate the effectiveness of such treatment in a selected population of patients."

Click here to see poster...

...................................................